BCR (Bacera Co. Pty Ltd), a well-established forex and CFD broker, is not only known for its robust trading platform and regulatory reliability but also for its growing commitment to corporate social responsibility. One standout initiative is its contribution to the advancement of neuroscience research through a dedicated PhD scholarship program.
In late 2019, BCR launched the BCR PhD Scholarship, an initiative fully funded by Bacera in collaboration with Dr. Chenyu Wang, Senior Lecturer at the Brain and Mind Centre (BMC), and the University of Sydney’s Nerve Research Foundation.
Investing in the Future of Medical Research
This scholarship supports a full-time PhD student undertaking a three-year project focused on identifying imaging biomarkers and uncovering the fundamental mechanisms behind neurodegenerative diseases. The research taps into breakthroughs in MRI technology and AI innovation, aiming to usher in a new era of precision medicine in the diagnosis and treatment of central nervous system disorders.
By aligning its philanthropic efforts with cutting-edge medical research, BCR demonstrates a vision that extends beyond financial markets. It reflects the company’s understanding of how technological innovation, data science, and health outcomes are increasingly interconnected.
A World-Class Research Environment
The selected scholar is embedded within the Computational Neuroscience Team at the Brain and Mind Centre. This environment offers rare interdisciplinary access to clinicians, computer scientists, imaging specialists, and AI researchers, enabling the student to benefit from rich mentorship and advanced research infrastructure.
This partnership not only supports academic excellence but also contributes to the global fight against neurodegenerative conditions like Alzheimer’s and Parkinson’s disease.
